Q4 2026 Earnings Call May 26, 2026 8:00 PM EDTCompany ParticipantsJames Bailey - Chief Executive OfficerSarah Pollard - ...
Massimiliano Moruzzi, founder and CEO of Xaba, is a longtime industrial automation and AI executive with deep expertise ...
Final Data from Phase 2 Expansion Study of NUC-7738 Expected in 2026 NUC-7738 Receives FDA IND Clearance: Planned Initial Studies to Focus on ...
AUCATZYL® (obecabtagene autoleucel; obe-cel) net product revenue of $26.2 million for the first quarter of 2026, reflecting strong launches in ...
AUCATZYL® (obecabtagene autoleucel; obe-cel) net product revenue of $26.2 million for the first quarter of 2026, reflecting strong launches in the US and most recently the UK Company achieves positive ...
EEST Record first quarter revenue, income and gross margin. Revenue grew by 45%, gross margin reached 94% and operating costs fell by 31% ...
Entered into an asset purchase agreement with Johnson & Johnson* (J&J) to acquire all interests in botaretigene sparoparvovec (bota-vec) for the treatment of X-linked retinitis pigmentosa (XLRP) ...
The world's most advanced AI models can't solve Sudoku. That matters.
Salem, May 22 -- Sona College of Technology has announced admissions to its four-year B.E., B.Tech programmes in Computer ...
The Trump administration has deported nearly 13,000 Cubans, Venezuelans and other nationals to Mexico, where they are ...
The updated 29-day course adds a week of tactical field training and simulated combat missions to the Army’s foundational NCO ...
Avacta Therapeutics (AIM: AVCT, “the Company”, “Avacta”), a clinical stage biopharmaceutical company developing pre|CISION, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results